Axplora leaders share how CDMO partnerships accelerate complex drug development and speed therapies to patients.

Editor's note: This article was updated at 1030a with comments from President Trump at a morning news conference and a statement from the Biotechnology Innovation Association. It was further updated ...

Healthcare is in the midst of a digital shift. Artificial intelligence offers physicians providers an new resource when making decisions, new data streams promise hyper-personalized treatments and ...

Advancements in gene therapy, biologics, and expanding global healthcare access drive steady 6.60% CAGR growth through 2035.Austin, United States, April 29, 2026 (GLOBE NEWSWIRE) -- According to SNS ...

As a tech lover, I soak it all in and leave inspired about what’s next. This was the case recently when I attended Google ...

The collaboration leverages Fosun Pharma’s research and manufacturing strengths, as well as Arcera’s access to international ...

Experts emphasize the need for a future-ready workforce to enhance India's global leadership in pharmaceuticals during a ...

Dublin, April 16, 2026 (GLOBE NEWSWIRE)-- The "Growth Opportunities in Global Pharmaceutical Industry, 2026" report has been added to ResearchAndMarkets.com's offering. The global pharmaceutical ...

WAKEFIELD, MA, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovation Pharmaceuticals (IPIX) (“the Company”), a clinical stage biopharmaceutical company and minority stakeholder in BT BeaMed ...

While India has built strong foundations in pharmaceuticals, the next phase of growth will require bold investments, deeper ecosystem collaboration, and a shift towards innovation-led development to p ...

Knoa Pharma is 100% owned by the newly established not-for-profit Knoa Foundation, a 501 (c) (4). This governance structure, which will ensure strong oversight of the company as it delivers on its ...